Conexiant’s news site is now MDSpire News. Learn more
Advertisement
What Will It Take to Control Continuous Biomanufacturing?
Review examines how PAT, model-based control, reinforcement learning, and digital twins could maintain product quality from perfusion culture through downstream purification
The article examines the objective, findings, and clinical context described in What Will It Take to Control Continuous Biomanufacturing?.
Approach:
Control methods: The review contrasts conventional PID control for stable, directly measured variables with model predictive control (MPC), which can forecast behavior and adjust multiple inputs under constraints.
Measurement and estimation: It discusses process analytical technology, in-line and online sensors, at-line sampling, and soft sensors for estimating attributes that cannot be measured directly.
Emerging tools and implementation: The review considers reinforcement learning and digital twins, and proposes a gradual path from decision support to supervisory optimization and controlled adjustments.
Key Findings:
Continuous processes must stay within operating and quality limits over extended periods while responding to disturbances, equipment drift, and interactions between connected operations.
PID control is suited to stable, clearly measured variables but is less effective when variables interact or measurements are delayed; MPC can address more complex, constrained control problems.
In a cited six-day filtration study, model-guided feedback control kept monoclonal antibody concentrations within 0.5–2.5% of setpoints and buffer exchange within 8% of its target.
Sensors can be costly to install and maintain and may experience calibration drift. At-line or automated sampling may be adequate for slower processes.
Soft-sensor estimates can be affected by sensor noise and model error, potentially leading to inappropriate control actions.
Reinforcement learning remains largely at the simulation and laboratory-demonstration stage; limited training data, safety and regulatory concerns, and low interpretability are barriers.
Digital twins could support testing, optimization, and algorithm training in a virtual environment.
Interpretation:
The review characterizes continuous biomanufacturing as a process-control and system-integration challenge. It proposes gradual implementation of digital-twin-supported control and states that advanced systems should be justified by measurable improvements in product recovery, consistency, or risk management.
Limitations:
The context does not provide the review's authors, publication details, or a source URL.
The cited filtration performance is one study example and does not establish performance across other processes.
Reinforcement learning is described as largely limited to simulations and laboratory demonstrations.